Core Viewpoint - Henry Schein, Inc. (HSIC) reported adjusted earnings per share (EPS) of 1.15forQ12025,reflectinga4.53.17 billion, a slight decline of 0.1% year-over-year, and fell short of the Zacks Consensus Estimate by 1.8% [3] - Constant currency total net sales increased by 1.4%, while excluding PPE and COVID-19 test kits, sales growth was 2% year-over-year [3] Segment Analysis - Global Distribution and Value-Added Services segment sales decreased by 0.7% to 2.68billion,witha0.8367 million, up 2% on a reported basis [6] - Global Technology segment sales reached 162million,reflectinga2.91.00 billion, a 1.2% decrease year-over-year, with gross margin contracting to 31.6% [8] - SG&A expenses decreased by 6.7% to 738million,whileadjustedoperatingprofitroseby18.6262 million [8] - The company ended Q1 2025 with cash and cash equivalents of 127million,upfrom122 million at the end of Q4 2024 [9] Share Repurchase and Guidance - HSIC repurchased approximately 2.3 million shares at an average price of 71.58,totalingaround161 million, with 718millionavailableforfuturerepurchases[10]−ThecompanymaintaineditsadjustedEPSforecastfor2025intherangeof4.80-$4.94, indicating 1-4% growth from 2024 [11] Strategic Outlook - HSIC is advancing its BOLD+1 Strategic Plan for 2025 to 2027, focusing on operational efficiency, enhancing customer experience, and expanding its digital solutions [13]